Cargando…
Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring
INTRODUCTION: X-linked adrenoleukodystrophy (X-ALD) is the most common inherited peroxisomal disorder caused by variants in the ABCD1 gene. The main phenotypes observed in men with X-ALD are primary adrenal insufficiency, adrenomyeloneuropathy, and cerebral ALD (cALD). Cerebral ALD consists of a dem...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869129/ https://www.ncbi.nlm.nih.gov/pubmed/36698902 http://dx.doi.org/10.3389/fneur.2022.1072256 |
_version_ | 1784876701404102656 |
---|---|
author | Bonaventura, Eleonora Alberti, Luisella Lucchi, Simona Cappelletti, Laura Fazzone, Salvatore Cattaneo, Elisa Bellini, Matteo Izzo, Giana Parazzini, Cecilia Bosetti, Alessandra Di Profio, Elisabetta Fiore, Giulia Ferrario, Matilde Mameli, Chiara Sangiorgio, Arianna Masnada, Silvia Zuccotti, Gian Vincenzo Veggiotti, Pierangelo Spaccini, Luigina Iascone, Maria Verduci, Elvira Cereda, Cristina Tonduti, Davide |
author_facet | Bonaventura, Eleonora Alberti, Luisella Lucchi, Simona Cappelletti, Laura Fazzone, Salvatore Cattaneo, Elisa Bellini, Matteo Izzo, Giana Parazzini, Cecilia Bosetti, Alessandra Di Profio, Elisabetta Fiore, Giulia Ferrario, Matilde Mameli, Chiara Sangiorgio, Arianna Masnada, Silvia Zuccotti, Gian Vincenzo Veggiotti, Pierangelo Spaccini, Luigina Iascone, Maria Verduci, Elvira Cereda, Cristina Tonduti, Davide |
author_sort | Bonaventura, Eleonora |
collection | PubMed |
description | INTRODUCTION: X-linked adrenoleukodystrophy (X-ALD) is the most common inherited peroxisomal disorder caused by variants in the ABCD1 gene. The main phenotypes observed in men with X-ALD are primary adrenal insufficiency, adrenomyeloneuropathy, and cerebral ALD (cALD). Cerebral ALD consists of a demyelinating progressive cerebral white matter (WM) disease associated with rapid clinical decline and is fatal if left untreated. Hematopoietic stem cell transplantation is the standard treatment for cALD as it stabilizes WM degeneration when performed early in the disease. For this reason, early diagnosis is crucial, and several countries have already implemented their newborn screening programs (NBS) with the assessment of C26:0-lysophosphatidylcholine (C26:0-LPC) values as screening for X-ALD. METHODS: In June 2021, an Italian group in Lombardy launched a pilot study for the implementation of X-ALD in the Italian NBS program. A three-tiered approach was adopted, and it involved quantifying the values of C26:0-LPC and other metabolites in dried blood spots with FIA-MS/MS first, followed by the more specific ultra-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) technique and, finally, the genetic confirmation via focused NGS. DISCUSSION: Genetically confirmed patients are set to undergo a follow-up protocol and are periodically evaluated to promptly start a specific treatment if and when the first signs of brain damage appear, as suggested by international guidelines. A specific disease monitoring protocol has been created based on literature data and personal direct experience. CONCLUSION: The primary aim of this study was to develop a model able to improve the early diagnosis and subsequent follow-up and timely treatment of X-ALD. ETHICS: The study was approved by the local ethics committee. The research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest. |
format | Online Article Text |
id | pubmed-9869129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98691292023-01-24 Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring Bonaventura, Eleonora Alberti, Luisella Lucchi, Simona Cappelletti, Laura Fazzone, Salvatore Cattaneo, Elisa Bellini, Matteo Izzo, Giana Parazzini, Cecilia Bosetti, Alessandra Di Profio, Elisabetta Fiore, Giulia Ferrario, Matilde Mameli, Chiara Sangiorgio, Arianna Masnada, Silvia Zuccotti, Gian Vincenzo Veggiotti, Pierangelo Spaccini, Luigina Iascone, Maria Verduci, Elvira Cereda, Cristina Tonduti, Davide Front Neurol Neurology INTRODUCTION: X-linked adrenoleukodystrophy (X-ALD) is the most common inherited peroxisomal disorder caused by variants in the ABCD1 gene. The main phenotypes observed in men with X-ALD are primary adrenal insufficiency, adrenomyeloneuropathy, and cerebral ALD (cALD). Cerebral ALD consists of a demyelinating progressive cerebral white matter (WM) disease associated with rapid clinical decline and is fatal if left untreated. Hematopoietic stem cell transplantation is the standard treatment for cALD as it stabilizes WM degeneration when performed early in the disease. For this reason, early diagnosis is crucial, and several countries have already implemented their newborn screening programs (NBS) with the assessment of C26:0-lysophosphatidylcholine (C26:0-LPC) values as screening for X-ALD. METHODS: In June 2021, an Italian group in Lombardy launched a pilot study for the implementation of X-ALD in the Italian NBS program. A three-tiered approach was adopted, and it involved quantifying the values of C26:0-LPC and other metabolites in dried blood spots with FIA-MS/MS first, followed by the more specific ultra-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) technique and, finally, the genetic confirmation via focused NGS. DISCUSSION: Genetically confirmed patients are set to undergo a follow-up protocol and are periodically evaluated to promptly start a specific treatment if and when the first signs of brain damage appear, as suggested by international guidelines. A specific disease monitoring protocol has been created based on literature data and personal direct experience. CONCLUSION: The primary aim of this study was to develop a model able to improve the early diagnosis and subsequent follow-up and timely treatment of X-ALD. ETHICS: The study was approved by the local ethics committee. The research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest. Frontiers Media S.A. 2023-01-09 /pmc/articles/PMC9869129/ /pubmed/36698902 http://dx.doi.org/10.3389/fneur.2022.1072256 Text en Copyright © 2023 Bonaventura, Alberti, Lucchi, Cappelletti, Fazzone, Cattaneo, Bellini, Izzo, Parazzini, Bosetti, Di Profio, Fiore, Ferrario, Mameli, Sangiorgio, Masnada, Zuccotti, Veggiotti, Spaccini, Iascone, Verduci, Cereda, Tonduti and XALD-NBS Study Group. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Bonaventura, Eleonora Alberti, Luisella Lucchi, Simona Cappelletti, Laura Fazzone, Salvatore Cattaneo, Elisa Bellini, Matteo Izzo, Giana Parazzini, Cecilia Bosetti, Alessandra Di Profio, Elisabetta Fiore, Giulia Ferrario, Matilde Mameli, Chiara Sangiorgio, Arianna Masnada, Silvia Zuccotti, Gian Vincenzo Veggiotti, Pierangelo Spaccini, Luigina Iascone, Maria Verduci, Elvira Cereda, Cristina Tonduti, Davide Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring |
title | Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring |
title_full | Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring |
title_fullStr | Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring |
title_full_unstemmed | Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring |
title_short | Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring |
title_sort | newborn screening for x-linked adrenoleukodystrophy in italy: diagnostic algorithm and disease monitoring |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869129/ https://www.ncbi.nlm.nih.gov/pubmed/36698902 http://dx.doi.org/10.3389/fneur.2022.1072256 |
work_keys_str_mv | AT bonaventuraeleonora newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT albertiluisella newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT lucchisimona newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT cappellettilaura newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT fazzonesalvatore newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT cattaneoelisa newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT bellinimatteo newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT izzogiana newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT parazzinicecilia newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT bosettialessandra newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT diprofioelisabetta newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT fioregiulia newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT ferrariomatilde newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT mamelichiara newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT sangiorgioarianna newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT masnadasilvia newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT zuccottigianvincenzo newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT veggiottipierangelo newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT spacciniluigina newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT iasconemaria newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT verducielvira newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT ceredacristina newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT tondutidavide newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring AT newbornscreeningforxlinkedadrenoleukodystrophyinitalydiagnosticalgorithmanddiseasemonitoring |